KBY Biotech Indexv0.0.34
Search
← Pipeline|CIP-213

CIP-213

Approved
By Cipla
Source: Trial-derived·Trials: 4
Modality
Vaccine
MOA
Menini
Target
Nectin-4
Pathway
Apoptosis
Gastric CaAtopic Derm
Development Pipeline
Preclinical
~Jun 2010
→ ~Sep 2011
Phase 1
~Dec 2011
→ ~Mar 2013
Phase 2
~Jun 2013
→ ~Sep 2014
Phase 3
~Dec 2014
→ ~Mar 2016
NDA/BLA
~Jun 2016
→ ~Sep 2017
Approved
Dec 2017
→ Aug 2030
ApprovedCurrent
NCT06345512
1,378 pts·Gastric Ca
2018-11→2030-08·Recruiting
NCT06386259
380 pts·Gastric Ca
2025-04→2026-02·Completed
NCT04445957
2,500 pts·Gastric Ca
2017-12→2026-08·Recruiting
+1 more trial
7,003 total pts1 indication
CompletedCurrentUpcoming
Catalysts (4)
2026-02-151mo agoPh3 Readout· Gastric Ca
2026-08-185mo awayPh3 Readout· Gastric Ca
2028-02-281.9y awayPh3 Readout· Gastric Ca
2030-08-044.3y awayPh3 Readout· Gastric Ca
Trial Timeline
Q42018Q2Q3Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2Q3Q42029Q2Q3Q42030Q2Q3Q4
Approved
Recruit…
Approved
Recruit…
Approved
Recruit…
Approved
Complet…
Catalysts
Ph3 Readout
2026-02-15 · 1mo ago
Gastric Ca
Ph3 Readout
2026-08-18 · 5mo away
Gastric Ca
Ph3 Readout
2028-02-28 · 1.9y away
Gastric Ca
Ph3 Readout
2030-08-04 · 4.3y away
Gastric Ca
RecruitingCompleted|StartCompletionToday
Trials (4)
NCTPhaseIndicationStatusNEP
NCT06345512ApprovedGastric CaRecruiting1378VA
NCT06386259ApprovedGastric CaCompleted380FEV1
NCT04445957ApprovedGastric CaRecruiting2500CR
NCT06843470ApprovedGastric CaRecruiting2745FEV1
Competitors (10)
DrugCompanyPhaseTargetMOA
MavutenlimabJohnson & JohnsonPhase 3Cl18.2Menini
IvorelsinEli LillyApprovedJAK1Menini
MRK-2473Merck & CoPhase 1/2Nectin-4TYK2i
NVO-2974Novo NordiskNDA/BLAPARPMenini
DSN-1421Daiichi SankyoPhase 3Nectin-4STINGag
ION-3857IonisPreclinicalNectin-4TYK2i
SemasacituzumabIlluminaPhase 3Nectin-4HPK1i
ElrainavolisibRoivant SciencesPreclinicalNectin-4FGFRi
IDY-3466Ideaya BioNDA/BLANectin-4FXIai
OlpafutibatinibImmunocoreApprovedSMN2Menini